Findings

What do systematic reviews say?

4,919 questions · 13,869 findings · 2,177 reviews · Headline outcomes only

Sort:Best matchNewestHighest certainty Download CSV

No studies found 13,869 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Direct antivirals (grazoprevir and elbasvir) vs placebo

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

Death · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

Relapse · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

Treatment discontinuation · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pegylated interferon + ribavirin (24 weeks) + initial telepravir (12 weeks) vs pegylated interferon (48 weeks) + initial telepravir (12 weeks) + initial low dose ribavirin (12 + 36 weeks)

Adverse events · patients on HD with HCV infection

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for dialysis patients with hepatitis C virus (HCV) infection 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cerebrolysin or Cerebrolysin‐like agents vs placebo

Death or dependence · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Cerebrolysin for acute ischaemic stroke 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cerebrolysin or Cerebrolysin‐like agents vs placebo

Early death (within 2 weeks of stroke onset) · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Cerebrolysin for acute ischaemic stroke 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cerebrolysin or Cerebrolysin‐like agents vs placebo

Quality of life · people with acute ischemic stroke

The review found no eligible studies for this question.

1 finding from 1 review

Cerebrolysin for acute ischaemic stroke 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: lower‐dose regimens vs standard‐dose strategies

Other neonatal morbidity · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen

Severe morbidity · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen

Side effects · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen

Other neonatal morbidity · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: loading dose alone vs loading dose + maintenance regimen

Severe morbidity · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery

Death of baby (up to discharge) · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery

Maternal death · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery

Other neonatal morbidity · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen

Severe morbidity · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment of eclampsia: loading dose alone vs loading dose + maintenance regimen

Side effects · women with eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen

Side effects · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen

Other neonatal morbidity · women with pre‐eclampsia

The review found no eligible studies for this question.

1 finding from 1 review

Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found